Showing results (611-620 of 6,760) with videos related to

Sort By:
Pageof 676
Clinical Therapeutics|September 1, 2004
Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studiesPeter Ball, Ralf Stahlmann, Rolf Kubin, et al.
Clinical Therapeutics|September 1, 2004
Effects of rivastigmine on behavioral and psychological symptoms of dementia in Alzheimer's diseaseSanford I Finkel
Clinical Therapeutics|September 1, 2004
Effects of granisetron in the treatment of nausea and vomiting after laparoscopic cholecystectomy: a dose-ranging studyYoshitaka Fujii, Hiroyoshi Tanaka, Tsuneo Kawasaki
Clinical Therapeutics|September 1, 2004
Comparison of cizolirtine citrate and metamizol sodium in the treatment of adult acute renal colic: a randomized, double-blind, clinical pilot studyIvan Pavlik, Jan Suchy, Dalibor Pacík, et al.
Clinical Therapeutics|September 1, 2004
Are English- and Chinese-language versions of the SF-6D equivalent? A comparison from a population-based studyHwee-Lin Wee, Yin-Bun Cheung, Kok-Yong Fong, et al.
Clinical Therapeutics|September 1, 2004
Management patterns and outcomes of patients with venous thromboembolism in the usual community practice settingVincent J Willey, Michael F Bullano, Ole Hauch, et al.
Clinical Therapeutics|September 1, 2004
A cost threshold analysis of ciprofloxacin-dexamethasone versus ofloxacin for acute otitis media in pediatric patients with tympanostomy tubesPeter S Roland, Allison Pontius, G Michael Wall, et al.
Clinical Therapeutics|January 1, 1992
Leuprorelin acetate depot vs danazol in the treatment of endometriosis: results of an open multicentre trialP G Crosignani, A Gastaldi, P L Lombardi, et al.
Clinical Therapeutics|June 29, 2004
Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, parallel-group trialMeng Tan, Don Johns, Guillermo González Gálvez, et al.
Clinical Therapeutics|June 29, 2004
Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) studySumit R Majumdar, Finlay A McAlister, Marilyn Cree, et al.
Pageof 676